To confirm whether the expression of PPARGC1A was indeed increased in TFE3 translocation-positive tRCC, the tumor tissues were stained with a PPARGC1A-specific antibody. This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.